WHO ICTRP trial
Evaluation of vancomycin pharmacokinetics in patients with augmented renal…
IRCT20180802040665N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20180802040665N1 |
|---|---|
| Public title | Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearance |
| Scientific title | Evaluation of vancomycin pharmacokinetics with two different regimens in patients with augmented renal clearance |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Augmented renal clearance. Abnormal results of kidney function studies;R94.4 |
| Interventions | Intervention 1: Intervention group: patients will be received intravenous vancomycin manufactured by Exir pharmaceutical company at dose of 15 to 20 mg/kg every 12 hours. The infusion rate of vancomycin is 1000 mg per hour. Intervention 2… |
| Registration date | Feb 20, 2021 |
| Target size | 56 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: